Sep 2026· Therapeutic Drug Monitoring· 0 citations· 8 references
Medicine
TL;DR
Nonlinear pharmacokinetic modeling successfully characterized caffeine elimination during severe intoxication and provided quantitative estimates of the duration of toxic exposure by providing quantitative estimates of the duration of toxic caffeine exposure.
Abstract
Background
Severe caffeine intoxication may result in life-threatening complications and prolonged toxicity due to its saturable metabolism. However, quantitative information regarding the duration of caffeine exposure is limited. Whether nonlinear pharmacokinetic modeling could support the prediction of toxic exposure duration in patients with severe caffeine intoxication was investigated.
Methods
A woman with severe caffeine intoxication was admitted to an intensive care unit. Serial serum caffeine concentrations were measured, and nonlinear pharmacokinetic analysis was conducted using a one-compartment model with Michaelis-Menten elimination. Model-based simulations were conducted to evaluate the concentration-time profiles across a range of initial serum caffeine concentrations.
Results
The initial serum caffeine concentration was 140.6 mcg/mL and decreased to 1.7 mcg/mL over 163 hours. Apparent elimination half-life decreased from 42.6 hours during the early phase to 11.2 hours during the late phase, suggesting concentration-dependent elimination. The proportional residual error model provided a better fit than the additive error model. Estimated Vmax and Km were 27.2 mg/h and 17.7 mcg/mL, respectively. The simulations demonstrated a marked concentration-dependent elimination of caffeine. For initial concentrations of 300, 200, and 100 mcg/mL, the predicted times required to decrease below 50 mcg/mL were 248, 154, and 55 hours, respectively.
Conclusions
Nonlinear pharmacokinetic modeling successfully characterized caffeine elimination during severe intoxication and provided quantitative estimates of the duration of toxic exposure. Model-based simulations may support clinical decision making regarding monitoring and treatment strategies by providing quantitative estimates of the duration of toxic caffeine exposure.
Hypokalemia serves as a promising, actionable clinical biomarker for severity assessment when massive ingestions saturate endogenous detoxification, hemodialysis becomes essential for survival.
Antonia Socias, Rafael Blancas· Frontiers in Toxicology· 0 citations
Background Voriconazole has marked pharmacokinetic variability and a narrow therapeutic window, making individualized dosing difficult. Published population pharmacokinetic (PopPK) models most derive from ICU or general-ward patients, and exposure-response studies are limited. This retrospective study aimed to characte...
Liu Yang, Ya-Ling Cao, Le-Tao Li et al.· Infection and Drug Resistanc...· 0 citations
This is the first published case describing cefepime PK in an adolescent on iHD and demonstrates the utility of model-informed precision dosing in this population.
Shannon Reinert, R. Morales, Emily R. Diseroad et al.· The Journal of Pediatric Pha...· 0 citations
This study quantified age‐related differences in fluoxetine pharmacokinetics and evaluated the influence of CYP2D6 phenotype using physiologically based pharmacokinetic (PBPK) modeling integrated with clinical therapeutic drug monitoring data. A PBPK model for fluoxetine and its active metabolite norfluoxetine was impl...
Y. Jang, D. Heo, Eunjin Hong· CPT: Pharmacometrics & Syste...· 0 citations
BACKGROUND
NH600001 is a novel intravenous anesthetic developed as a safer alternative to etomidate. Its pharmacokinetic/pharmacodynamic (PK/PD) profile and optimal dosing in elderly patients remain insufficiently characterized. This study aimed to develop a population PK/PD model of NH600001 and evaluate age‑related d...
Ya-Jie Cao, Yun Kuang, Qi Gao et al.· Expert Opinion on Drug Metab...· 0 citations
Lithium is a cornerstone pharmacotherapy for bipolar disorders; however, its narrow therapeutic index complicates clinical management. 1 We pre-sent an unusual case of severe, protracted lithium intoxication after only 5 days of low-dose exposure, characterized by a delayed serum surge 10 days post-discontinuation and...